ArticleESMO open2020

Correction: Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.